Levetiracetam Treatment of L-dopa Induced Dyskinesias

NCT00076674 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

NIH

Sponsor class

Conditions

Dyskinesias
Parkinson Disease

Interventions

DRUG: Intravenous Levodopa

Sponsor

National Institute of Neurological Disorders and Stroke (NINDS)